Literature DB >> 23650938

Circadian rhythms in acute intermittent porphyria--a pilot study.

Sebastian Larion1, Frederick R Caballes, Sun-Il Hwang, Jin-Gyun Lee, Whitney E Rossman, Judy Parsons, Nury Steuerwald, Ting Li, Vinaya Maddukuri, Gale Groseclose, Carla V Finkielstein, Herbert L Bonkovsky.   

Abstract

BACKGROUND: Acute intermittent porphyria (AIP) is an inherited disorder of haem synthesis wherein a partial deficiency of porphobilinogen (PBG) deaminase (PBGD) with other factors may give rise to biochemical and clinical manifestations of disease. The biochemical hallmarks of active AIP are relative hepatic haem deficiency and uncontrolled up-regulation of hepatic 5-aminolevulinic acid (ALA) synthase-1 (ALAS1) with over-production of ALA and PBG. The treatment of choice is intravenous haem, which restores the deficient regulatory haem pool of the liver and represses ALAS1. Recently, haem has been shown to influence circadian rhythms by controlling their negative feedback loops. We evaluated whether subjects with AIP exhibited an altered circadian profile.
MATERIALS AND METHODS: Over a 21-h period, we measured levels of serum cortisol, melatonin, ALA, PBG and mRNA levels (in peripheral blood mononuclear cells) of selected clock-controlled genes and genes involved in haem synthesis in 10 Caucasian (European-American) women who were either postmenopausal or had been receiving female hormone therapy, six of whom have AIP and four do not and are considered controls.
RESULTS: Four AIP subjects with biochemical activity exhibited higher levels of PBG and lower levels and dampened oscillation of serum cortisol, and a trend for lower levels of serum melatonin, than controls or AIP subjects without biochemical activity. Levels of clock-controlled gene mRNAs showed significant increases over baseline in all subjects at 5 a.m. and 11 p.m., whereas mRNA levels of ALAS1, ALAS2 and PBGD were increased only at 11 p.m. in subjects with active AIP.
CONCLUSIONS: This pilot study provides evidence for disturbances of circadian markers in women with active AIP that may trigger or sustain some common clinical features of AIP.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23650938      PMCID: PMC3687345          DOI: 10.1111/eci.12102

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  49 in total

Review 1.  Health in a 24-h society.

Authors:  S M Rajaratnam; J Arendt
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

2.  Combined liver and kidney transplantation in acute intermittent porphyria.

Authors:  Staffan Wahlin; Pauline Harper; Eliane Sardh; Christer Andersson; Dan Eh Andersson; Bo-Göran Ericzon
Journal:  Transpl Int       Date:  2009-12-16       Impact factor: 3.782

3.  An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.

Authors:  K L Toh; C R Jones; Y He; E J Eide; W A Hinz; D M Virshup; L J Ptácek; Y H Fu
Journal:  Science       Date:  2001-02-09       Impact factor: 47.728

Review 4.  Circadian-system alterations during cancer processes: a review.

Authors:  M C Mormont; F Lévi
Journal:  Int J Cancer       Date:  1997-01-17       Impact factor: 7.396

5.  Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock.

Authors:  B Zheng; U Albrecht; K Kaasik; M Sage; W Lu; S Vaishnav; Q Li; Z S Sun; G Eichele; A Bradley; C C Lee
Journal:  Cell       Date:  2001-06-01       Impact factor: 41.582

6.  Relationship between circadian oscillations of Rev-erbalpha expression and intracellular levels of its ligand, heme.

Authors:  Pamela M Rogers; Ling Ying; Thomas P Burris
Journal:  Biochem Biophys Res Commun       Date:  2008-02-15       Impact factor: 3.575

7.  Liver transplantation as a cure for acute intermittent porphyria.

Authors:  Zahir F Soonawalla; Taner Orug; Michael N Badminton; George H Elder; Jonathan M Rhodes; Simon R Bramhall; Elwyn Elias
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

8.  Elevated urinary excretion of beta-aminoisobutyric acid and delta-aminolevulinic acid (ALA) and the inhibition of ALA-synthase and ALA-dehydratase activities in both liver and kidney in mice exposed to lead.

Authors:  K Tomokuni; M Ichiba; Y Hirai
Journal:  Toxicol Lett       Date:  1991-12       Impact factor: 4.372

Review 9.  Melatonin as a biomarker of circadian dysregulation.

Authors:  Dana K Mirick; Scott Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

10.  Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.

Authors:  Joanna K Dowman; Bridget K Gunson; Darius F Mirza; Simon R Bramhall; Mike N Badminton; Philip N Newsome
Journal:  Liver Transpl       Date:  2012-02       Impact factor: 5.799

View more
  5 in total

1.  Characterization of the hepatic transcriptome following phenobarbital induction in mice with AIP.

Authors:  Brenden Chen; Minghui Wang; Lin Gan; Bin Zhang; Robert J Desnick; Makiko Yasuda
Journal:  Mol Genet Metab       Date:  2019-01-06       Impact factor: 4.797

2.  Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.

Authors:  Herbert L Bonkovsky; Vinaya C Maddukuri; Cemal Yazici; Karl E Anderson; D Montgomery Bissell; Joseph R Bloomer; John D Phillips; Hetanshi Naik; Inga Peter; Gwen Baillargeon; Krista Bossi; Laura Gandolfo; Carrie Light; David Bishop; Robert J Desnick
Journal:  Am J Med       Date:  2014-07-10       Impact factor: 4.965

3.  Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine.

Authors:  Jingyun Lee; Kimberly Q McKinney; Antonis J Pavlopoulos; Meng Niu; Jung Won Kang; Jae Won Oh; Kwang Pyo Kim; Sunil Hwang
Journal:  Mol Cells       Date:  2018-03-09       Impact factor: 5.034

4.  Multiplexed Visualization Method to Explore Complete Targeting Regulatory Relationships Among Circadian Genes for Insomnia Treatment.

Authors:  Tao Li; Zhenyu Liu; Yitong Wang; Dongshi Zuo; Shenyuan Wang; Haitao Ju; Shichao Wang; Yanping Xing; Yu Ling; Chunxia Liu; Yanru Zhang; Huanmin Zhou; Jun Yin; Junwei Cao; Jing Gao
Journal:  Front Neurosci       Date:  2022-07-01       Impact factor: 5.152

5.  Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study.

Authors:  Oscar J Pozo; Josep Marcos; Andreu Fabregat; Rosa Ventura; Gregori Casals; Paula Aguilera; Jordi Segura; Jordi To-Figueras
Journal:  Orphanet J Rare Dis       Date:  2014-04-16       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.